Clinical Trial Update: Multicentric Study, Three Randomized Arms (R-CVP vs R-CHOP vs R-FM),for Patients With Stage II-IV Follicular Lymphoma [Phase 3]

View source ↗

Summary

A Phase 3 multicenter randomized trial comparing three rituximab-containing regimens (R-CVP, R-CHOP, and R-FM) in patients with stage II-IV Follicular lymphoma.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Follicular Lymphoma

Drugs mentioned

• Adriamycin (doxorubicin)
• Cytoxan (cyclophosphamide)
• Deltasone (prednisone)
• Fludara (fludarabine)
• Novantrone (mitoxantrone)
• Oncovin (vincristine)
• Rituxan (rituximab)

Snippet

Sponsor: Fondazione Italiana Linfomi - ETS | Conditions: Follicular Lymphoma | Phase 3 | Status: UNKNOWN